COLORECTAL CANCER
Dwi Kartika Rukmi
Morphology of Colon
CANCER
WORLWID
E
COLORECTAL CANCER
 Colorectal cancer (CRC) is a major cause of
morbidity and mortality throughout the
world. It accounts for over 9% of all cancer
incidence.
 CRC is the third most common cancer
worldwide and the fourth most common
cause of death
 In 2012, highest CRC incidence in both female
and male are in Japan (Miyagi Prefecture: ♀
37,2/100.000 and ♂ 62,4/100.000)
Arnold M, Sierra MS, Laversanne M, et al. Gut 2017;66:683–691
COLORECTAL CANCER RISK FACTOR
NON MODIFIABLE (20%)
 Age
 Personal History of Adenomatous Polyps
 Personal History of Inflammatory Bowel
Disease
 Family History of Colorectal Cancer or
Adenomatous Polyps
 Inherited Genetic Risk
MODIFIABLE (80%)
 A diet low in fibre, vegetables, and folate and
high in fat, red meat
 Heavy alcohol consumption
 A sedentary occupation
 Cigarette smoking
Hamza, Aglan, Ahmed,2017; Granados Romero JJ et al. 2017
Cont
 Age: increases progressively from age 40,
rising sharply after 50.
 Personal History of Adenomatous Polyps
: tubular or villous adenomas (life time
risk for adenomas is 19% and 95% CRC
develops from these adenomas)
Villous Adenoma
Tubular AdenomaHamza, Aglan, Ahmed,2017; Granados Romero JJ et al. 2017
Cont
 Personal History of Inflammatory Bowel
Disease :Ulcerative colitis and Crohn
disease usually described as inflammatory
bowel disease (IBD) . The relative risk of
CRC in patients with inflammatory bowel
disease has been estimated between 4-
to 20-fold
 Family History of Colorectal Cancer or
Adenomatous Polyps :People with a
history of CRC or adenomatous polyps in
one or more first-degree relatives are at
increased risk. CRC develop 100% in FAP
untreated by age 45
Ulcerative colitis
Familial
Adenomatous
Polyps (FAP)
Hamza, Aglan, Ahmed,2017
Cont
 Inherited Genetic Risk
 Approximately 5 to 10% of colorectal cancers are a
consequence of recognized hereditary conditions. The most
common inherited conditions are FAP and HNPCC, also
called Lynch syndrome
 HNPCC is associated with mutations in genes involved in the
DNA repair pathway
 FAP is caused by mutations in the tumor suppressor gene
APC
 The lifetime risk of CRC in people with the recognized
HNPCC-related mutations may be as high as 70 to 80%, and
the average age at diagnosis in their mid-40s
Hamza, Aglan, Ahmed,2017
 A diet low in fibre, vegetables, and
folate and high in fat, red meat
Hamza, Aglan, Ahmed,2017
Cont
 Alcohol comsumption
Rossi, M.,Anwar MJ.,Usman A.,et al. 2017
Cont
 A sedentary occupation
Hamza, Aglan, Ahmed,2017
Cont
 Cigarette Smoking
Liang, 2009
Pathophysiology of CRC (Nguyen, Duong, 2018)
LOCATION OF CRC
 Rectum (37%)
 Sigmoid (31%)
 Ascending colon (9%)
 Cecum (8%)
 Descending colon (5%)
 Transverse colon (4%)
 Hepatic angle (4%)
 Splenic Angle (2%)
Granados Romero JJ et al. 2017
SYMPTOM OF CRC
 Bleeding from the rectum
 Blood in the stool or in the toilet after having a bowel movement
 Dark or black stools
 A change in the shape of the stool (e.g., more narrow than usual)
 Cramping or discomfort in the lower abdomen
 An urge to have a bowel movement when the bowel is empty
 Constipation or diarrhea that lasts for few days
 Decreased appetite
 Unintentional weight loss
 Anemia from blood loss causes weakness and fatique
Hamza, Aglan, Ahmed,2017
DIAGNOSIS OF CRC (Granados Romero JJ et al. 2017)
Cont
Cont
STAGING OF CRC (Venook,2019; Hamza,Aglan ,Ahmed,2017)
STAGING
OF CRC
(AJCC,2010)
TREATMENT OF CRC (Granados Romero JJ et al. 2017)
 Stage 0 cancer can be treated by removing cancer cells by colonoscopy.
 Stage I, II and III Cancer, it is necessary to perform surgery using radical colectomy of the segment involved with margins > 5
cm, lymphadenectomy to the root of the nutrient vessel (minimum 12N), suspicious ganglion biopsy outside the resection
field It has been demonstrated that the laparoscopic approach is as safe as the traditional open approach for colorectal
cancer.
 Stage III: also treatment with radiotherapy combination with chemotherapy
 Chemotherapy (Fluorouracil and Leucovorin)  complementary chemotherapy for Stage III after surgery for 6-8 months for
improving symptom and prolong survival
 The 5 - Fluoracil continues to be the cytostatic mostly used in the treatment of colon cancer, those who make use of it or at
least approach the fulfilment of the therapeutic standard, achieve better percentages of survival.
 Anti angiogenesis therapy: Bevacizumab (lowering vascular endothelial growth factor (VEGF). Anti angiogenesis +
chemotherapy is better than chemotherapy only  improve global survival
 Stage IV with metastatic : various therapy approaches (ablation, chemotherapy, radiotherapy, cryotherapy or surgery)
Colonoscopy
SURGERY OF CRC
TOP TEN REPORT OF CRC PATIENTS
 Worry, anxiety or fear
 Information needs
 Fatigue
 Constipation or diarrhea
 Making plans
 Pain
 Sleep problems
 Tingling in hands and feet
 Work or education
 Other medical condition
NHS,2015
NURSING DIAGNOSIS
 Anxiety
 Deficient knowledge
 Fatigue
 Constipation
 Diarrhea
 Pain
 Disturbed Sleep Pattern
 Fear
NOC
Diagnosis NOC
Anxiety • Anxiety control
• Coping
Deficient knowledge • Diseases Process
• Health behavior
Fatigue • Energy conservation
• Nutritional status: energy
Constipation Bowel elimination
Diarrhea Bowel elimination
Pain • Pain Level
• Pain Control
Disturbed Sleep Pattern • Sleep
• Rest
Fear Fear control
NIC
Diagnosis NIC
Anxiety • Anxiety reduction
Deficient knowledge • Teaching: diseases process
• Teaching: individual
Fatigue • Energy management
Constipation Constipation/Impaction Management
Diarrhea Diarrhea management
Pain • Pain management
• Analgesic administration
Disturbed Sleep Pattern • Sleep enhancement
Fear Coping enhancement
 Arnold M, Sierra MS, Laversanne M, et al. Gut 2017;66:683–691 dalam https://gut.bmj.com/content/gutjnl/66/4/683.full.pdf
 Hamza AH,Aglan AH,Ahmed HH.2017. dalam http://www.avidscience.com/wp-content/uploads/2017/04/RAC0C-15-06.pdf
 Granados Romero JJ et al. 2017. Int J Res Med Sci. Nov 5(11):4667-4676 dalam https://www.researchgate.net/publication/320676335_Colorectal_cancer_a_review
 Rossi, M.,Anwar MJ.,Usman A.,et al. 2017 dalam https://pdfs.semanticscholar.org/a1ae/a03533995169bf2dc3ac66db6ffb6108bcdf.pdf
 Liang,P. 2009. Int. J. Cancer: 124, 2406–2415 dalam
https://www.researchgate.net/publication/23786425_Cigarette_smoking_and_colorectal_cancer_incidence_and_mortality_Systematic_review_and_meta-analysis
 Dulai,PS.,Sunborn,WJ.,Gupta,S.2016 dalam http://cancerpreventionresearch.aacrjournals.org/content/9/12/887
 Venook,AP.2019 dalam https://www.medscape.org/viewarticle/501381
 Nguyen,HT.,Duong,HQ.2018 dalam https://www.spandidos-publications.com/ol/16/1/9
 NHS.2015 dalam https://www.england.nhs.uk/wp-content/uploads/2015/03/colorectal-cancer-proms-report-140314.pdf

More Related Content

PDF
Popescu razvan gastric cancer locally advanced
PPTX
Colon cancer
PPTX
Breast screening
PPTX
Pancreatic Cancer
PPTX
Genetic assays in breast cancer
PPTX
Management Guideline in Colorectal Cancer.pptx
PPTX
BRCA – Importance in Hereditary Breast & Ovarian Cancer
PPTX
Understanding BRCA1/2 Cancer Risk
Popescu razvan gastric cancer locally advanced
Colon cancer
Breast screening
Pancreatic Cancer
Genetic assays in breast cancer
Management Guideline in Colorectal Cancer.pptx
BRCA – Importance in Hereditary Breast & Ovarian Cancer
Understanding BRCA1/2 Cancer Risk

What's hot (20)

PPTX
Chapter 5 hereditary cancer syndrome next generation
PPT
Breast Adjuvant Chemotherapy
PPT
Cancer PPT (From Mrs. Brenda Lee)
PPTX
Targeted Therapies for Breast Cancer
PPT
HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.
PPT
Oncotype dx
PPTX
Esophageal cancer-role of RT
PPTX
Adjuvant therapy for colon adenocarcinoma
PPT
Colorectal cancer
PPTX
metastatic colorectal cancer; a new chapter in the story
PPTX
Genetic testing in breast cancer
PPTX
Anal canal cancer
PPTX
MANAGEMENT OF TRIPLE NEGATIVE BREAST CANCER.pptx
PPTX
EVOLUTION OF CHEMOTHERAPY IN BREAST CANCER
PPT
Adjuvant treatment in early and localy advanced breast cancer
PPTX
Oncotype dx presentation
PPTX
Role of chemotherapy in carcinoma stomach
PPTX
Portec trial ppt
PPTX
Ca cervix—standards of care
PPTX
Adjuvant chemotherapy of breast cancer
Chapter 5 hereditary cancer syndrome next generation
Breast Adjuvant Chemotherapy
Cancer PPT (From Mrs. Brenda Lee)
Targeted Therapies for Breast Cancer
HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.
Oncotype dx
Esophageal cancer-role of RT
Adjuvant therapy for colon adenocarcinoma
Colorectal cancer
metastatic colorectal cancer; a new chapter in the story
Genetic testing in breast cancer
Anal canal cancer
MANAGEMENT OF TRIPLE NEGATIVE BREAST CANCER.pptx
EVOLUTION OF CHEMOTHERAPY IN BREAST CANCER
Adjuvant treatment in early and localy advanced breast cancer
Oncotype dx presentation
Role of chemotherapy in carcinoma stomach
Portec trial ppt
Ca cervix—standards of care
Adjuvant chemotherapy of breast cancer
Ad

Similar to Colorectal cancer/ Kanker Kolorektal (20)

PPT
GI and Liver Malignancies
PPTX
CES201701-Clase 6 (Tumores gastrointestinales)
PPTX
PPTX
SPECIFIC CANCERS- BREAST, OVARIAN, CERVICAL, PROSTATE, GASTRIC & LUNG CA.pptx
PPT
Oncology Introduction.
PPT
Medicine 5th year, 1st & 2nd/part one lectures (Dr. Abdulla Sharief)
PPT
colorectal cancer - diagnosis, treatment.ppt
PPTX
pancreatic cancer management
PPT
Colorectal cancer: A brief review
PPTX
MSN I 30.6.2020 AN Unit IV Pancreas cancer.pptx
PPT
f-perez-lopez-endometrial-cancer-others.ppt
PPTX
Colorectal.pptx
PPTX
Neoplasms of the stomach
PPT
CRC for 5th.
PPTX
colorectal class.pptx
PPTX
CES 2016 02 - Colorectal cancer
PPTX
Carcinoma stomach- A Brief Overview- Part 1
PPTX
Carcinoma Colorectal
PPTX
Genesilencing in Breast Cancer
PPTX
Gene silencing in Breast cancer
GI and Liver Malignancies
CES201701-Clase 6 (Tumores gastrointestinales)
SPECIFIC CANCERS- BREAST, OVARIAN, CERVICAL, PROSTATE, GASTRIC & LUNG CA.pptx
Oncology Introduction.
Medicine 5th year, 1st & 2nd/part one lectures (Dr. Abdulla Sharief)
colorectal cancer - diagnosis, treatment.ppt
pancreatic cancer management
Colorectal cancer: A brief review
MSN I 30.6.2020 AN Unit IV Pancreas cancer.pptx
f-perez-lopez-endometrial-cancer-others.ppt
Colorectal.pptx
Neoplasms of the stomach
CRC for 5th.
colorectal class.pptx
CES 2016 02 - Colorectal cancer
Carcinoma stomach- A Brief Overview- Part 1
Carcinoma Colorectal
Genesilencing in Breast Cancer
Gene silencing in Breast cancer
Ad

More from DwiKartikaRukmi (16)

PPTX
Circulatory Shock Managements
PPTX
Hiv basic concept
PPTX
Skin cancer
PDF
Nursing care of Stroke
PPTX
Assessment and management of pain
PPTX
Assesment, interpretation n management of cranial nerve dysfunction
PPTX
Px neurologi fix
PPTX
Occupational lung diseases
PPTX
Anatomi fisiologi saraf (neuron)
PPTX
Konsep dasar stroke
PPTX
Konsep & asuhan keperawatan pasien hiv
PPTX
Meningitis
PPTX
Assessment and management of challenging behaviour
PPTX
Altered consciousness
PPTX
Anatomi Fisiologi Otak
PPTX
Tumor otak 3.2
Circulatory Shock Managements
Hiv basic concept
Skin cancer
Nursing care of Stroke
Assessment and management of pain
Assesment, interpretation n management of cranial nerve dysfunction
Px neurologi fix
Occupational lung diseases
Anatomi fisiologi saraf (neuron)
Konsep dasar stroke
Konsep & asuhan keperawatan pasien hiv
Meningitis
Assessment and management of challenging behaviour
Altered consciousness
Anatomi Fisiologi Otak
Tumor otak 3.2

Recently uploaded (20)

PDF
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
PDF
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PPTX
Computed Tomography: Hardware and Instrumentation
PPTX
RESEARCH APPROACH & DESIGN.pptx presented by preeti kulshrestha
PPTX
ENT-DISORDERS ( ent for nursing ). (1).p
PPTX
PSYCHIATRIC SEQUALAE OF HEAD INJURY.pptx
PDF
heliotherapy- types and advantages procedure
PDF
FMCG-October-2021........................
PPTX
LIVER DIORDERS OF PREGNANCY in detail PPT.pptx
PPTX
Bronchial Asthma2025 GINA Guideline.pptx
PPTX
Approch to weakness &paralysis pateint.pptx
PPTX
IMMUNITY ... and basic concept mds 1st year
PPTX
Indications for Surgical Delivery...pptx
PDF
Demography and community health for healthcare.pdf
PPTX
Emergencies in Anaesthesia by Dr SAMI.pptx
PDF
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
PPTX
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
PPTX
critical care nursing 12.pptxhhhhhhhhjhh
PDF
NCCN CANCER TESTICULAR 2024 ...............................
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
Computed Tomography: Hardware and Instrumentation
RESEARCH APPROACH & DESIGN.pptx presented by preeti kulshrestha
ENT-DISORDERS ( ent for nursing ). (1).p
PSYCHIATRIC SEQUALAE OF HEAD INJURY.pptx
heliotherapy- types and advantages procedure
FMCG-October-2021........................
LIVER DIORDERS OF PREGNANCY in detail PPT.pptx
Bronchial Asthma2025 GINA Guideline.pptx
Approch to weakness &paralysis pateint.pptx
IMMUNITY ... and basic concept mds 1st year
Indications for Surgical Delivery...pptx
Demography and community health for healthcare.pdf
Emergencies in Anaesthesia by Dr SAMI.pptx
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
critical care nursing 12.pptxhhhhhhhhjhh
NCCN CANCER TESTICULAR 2024 ...............................

Colorectal cancer/ Kanker Kolorektal

  • 4. COLORECTAL CANCER  Colorectal cancer (CRC) is a major cause of morbidity and mortality throughout the world. It accounts for over 9% of all cancer incidence.  CRC is the third most common cancer worldwide and the fourth most common cause of death  In 2012, highest CRC incidence in both female and male are in Japan (Miyagi Prefecture: ♀ 37,2/100.000 and ♂ 62,4/100.000) Arnold M, Sierra MS, Laversanne M, et al. Gut 2017;66:683–691
  • 5. COLORECTAL CANCER RISK FACTOR NON MODIFIABLE (20%)  Age  Personal History of Adenomatous Polyps  Personal History of Inflammatory Bowel Disease  Family History of Colorectal Cancer or Adenomatous Polyps  Inherited Genetic Risk MODIFIABLE (80%)  A diet low in fibre, vegetables, and folate and high in fat, red meat  Heavy alcohol consumption  A sedentary occupation  Cigarette smoking Hamza, Aglan, Ahmed,2017; Granados Romero JJ et al. 2017
  • 6. Cont  Age: increases progressively from age 40, rising sharply after 50.  Personal History of Adenomatous Polyps : tubular or villous adenomas (life time risk for adenomas is 19% and 95% CRC develops from these adenomas) Villous Adenoma Tubular AdenomaHamza, Aglan, Ahmed,2017; Granados Romero JJ et al. 2017
  • 7. Cont  Personal History of Inflammatory Bowel Disease :Ulcerative colitis and Crohn disease usually described as inflammatory bowel disease (IBD) . The relative risk of CRC in patients with inflammatory bowel disease has been estimated between 4- to 20-fold  Family History of Colorectal Cancer or Adenomatous Polyps :People with a history of CRC or adenomatous polyps in one or more first-degree relatives are at increased risk. CRC develop 100% in FAP untreated by age 45 Ulcerative colitis Familial Adenomatous Polyps (FAP) Hamza, Aglan, Ahmed,2017
  • 8. Cont  Inherited Genetic Risk  Approximately 5 to 10% of colorectal cancers are a consequence of recognized hereditary conditions. The most common inherited conditions are FAP and HNPCC, also called Lynch syndrome  HNPCC is associated with mutations in genes involved in the DNA repair pathway  FAP is caused by mutations in the tumor suppressor gene APC  The lifetime risk of CRC in people with the recognized HNPCC-related mutations may be as high as 70 to 80%, and the average age at diagnosis in their mid-40s Hamza, Aglan, Ahmed,2017
  • 9.  A diet low in fibre, vegetables, and folate and high in fat, red meat Hamza, Aglan, Ahmed,2017
  • 10. Cont  Alcohol comsumption Rossi, M.,Anwar MJ.,Usman A.,et al. 2017
  • 11. Cont  A sedentary occupation Hamza, Aglan, Ahmed,2017
  • 13. Pathophysiology of CRC (Nguyen, Duong, 2018)
  • 14. LOCATION OF CRC  Rectum (37%)  Sigmoid (31%)  Ascending colon (9%)  Cecum (8%)  Descending colon (5%)  Transverse colon (4%)  Hepatic angle (4%)  Splenic Angle (2%) Granados Romero JJ et al. 2017
  • 15. SYMPTOM OF CRC  Bleeding from the rectum  Blood in the stool or in the toilet after having a bowel movement  Dark or black stools  A change in the shape of the stool (e.g., more narrow than usual)  Cramping or discomfort in the lower abdomen  An urge to have a bowel movement when the bowel is empty  Constipation or diarrhea that lasts for few days  Decreased appetite  Unintentional weight loss  Anemia from blood loss causes weakness and fatique Hamza, Aglan, Ahmed,2017
  • 16. DIAGNOSIS OF CRC (Granados Romero JJ et al. 2017)
  • 17. Cont
  • 18. Cont
  • 19. STAGING OF CRC (Venook,2019; Hamza,Aglan ,Ahmed,2017)
  • 21. TREATMENT OF CRC (Granados Romero JJ et al. 2017)  Stage 0 cancer can be treated by removing cancer cells by colonoscopy.  Stage I, II and III Cancer, it is necessary to perform surgery using radical colectomy of the segment involved with margins > 5 cm, lymphadenectomy to the root of the nutrient vessel (minimum 12N), suspicious ganglion biopsy outside the resection field It has been demonstrated that the laparoscopic approach is as safe as the traditional open approach for colorectal cancer.  Stage III: also treatment with radiotherapy combination with chemotherapy  Chemotherapy (Fluorouracil and Leucovorin)  complementary chemotherapy for Stage III after surgery for 6-8 months for improving symptom and prolong survival  The 5 - Fluoracil continues to be the cytostatic mostly used in the treatment of colon cancer, those who make use of it or at least approach the fulfilment of the therapeutic standard, achieve better percentages of survival.  Anti angiogenesis therapy: Bevacizumab (lowering vascular endothelial growth factor (VEGF). Anti angiogenesis + chemotherapy is better than chemotherapy only  improve global survival  Stage IV with metastatic : various therapy approaches (ablation, chemotherapy, radiotherapy, cryotherapy or surgery)
  • 24. TOP TEN REPORT OF CRC PATIENTS  Worry, anxiety or fear  Information needs  Fatigue  Constipation or diarrhea  Making plans  Pain  Sleep problems  Tingling in hands and feet  Work or education  Other medical condition NHS,2015
  • 25. NURSING DIAGNOSIS  Anxiety  Deficient knowledge  Fatigue  Constipation  Diarrhea  Pain  Disturbed Sleep Pattern  Fear
  • 26. NOC Diagnosis NOC Anxiety • Anxiety control • Coping Deficient knowledge • Diseases Process • Health behavior Fatigue • Energy conservation • Nutritional status: energy Constipation Bowel elimination Diarrhea Bowel elimination Pain • Pain Level • Pain Control Disturbed Sleep Pattern • Sleep • Rest Fear Fear control
  • 27. NIC Diagnosis NIC Anxiety • Anxiety reduction Deficient knowledge • Teaching: diseases process • Teaching: individual Fatigue • Energy management Constipation Constipation/Impaction Management Diarrhea Diarrhea management Pain • Pain management • Analgesic administration Disturbed Sleep Pattern • Sleep enhancement Fear Coping enhancement
  • 28.  Arnold M, Sierra MS, Laversanne M, et al. Gut 2017;66:683–691 dalam https://gut.bmj.com/content/gutjnl/66/4/683.full.pdf  Hamza AH,Aglan AH,Ahmed HH.2017. dalam http://www.avidscience.com/wp-content/uploads/2017/04/RAC0C-15-06.pdf  Granados Romero JJ et al. 2017. Int J Res Med Sci. Nov 5(11):4667-4676 dalam https://www.researchgate.net/publication/320676335_Colorectal_cancer_a_review  Rossi, M.,Anwar MJ.,Usman A.,et al. 2017 dalam https://pdfs.semanticscholar.org/a1ae/a03533995169bf2dc3ac66db6ffb6108bcdf.pdf  Liang,P. 2009. Int. J. Cancer: 124, 2406–2415 dalam https://www.researchgate.net/publication/23786425_Cigarette_smoking_and_colorectal_cancer_incidence_and_mortality_Systematic_review_and_meta-analysis  Dulai,PS.,Sunborn,WJ.,Gupta,S.2016 dalam http://cancerpreventionresearch.aacrjournals.org/content/9/12/887  Venook,AP.2019 dalam https://www.medscape.org/viewarticle/501381  Nguyen,HT.,Duong,HQ.2018 dalam https://www.spandidos-publications.com/ol/16/1/9  NHS.2015 dalam https://www.england.nhs.uk/wp-content/uploads/2015/03/colorectal-cancer-proms-report-140314.pdf

Editor's Notes

  • #14: Figure 1. - Colorectal adenoma-carcinoma sequence. The APC mutation is the first step transforming normal colorectal epithelium to adenoma. The adenoma-carcinoma sequence is caused by three major pathways: CIN, MSI and CIMP. CIN, Chromosomal instability; MSI, microsatellite instability; CIMP, CpG island methylator phenotype; APC, adenomatous polyposis; KRAS, KRAS proto-oncogene GTPase; BRAF, B-Raf proto-oncogene serine/threonine kinase; TP53, tumor protein 53; LOH, loss of heterozygosity; HNPPC, hereditary non-polyposis colorectal cancer; MLH1, mutL homolog 1; MSH2, mutS homolog 2; DCC, DCC netrin 1 receptor; TGFBR, transforming growth factor-β receptor; BAX, BCL2 associated X apoptosis regulator; IGF2R, insulin like growth factor 2 receptor; CDC4, cell division control protein 4